Wallace Wallace
Senior Associate, Independent Investments
Wallace is part of the Independent Investments Team at Oxford Science Enterprises, focusing on supporting portfolio companies beyond the venture-building phase. She brings scientific and strategic insight to investment reviews, due diligence, and the deployment of new capital.
She joined OSE in 2022 from M Ventures, Merck KGaA’s corporate VC arm, where she focused on life sciences investments. Earlier in her career, she worked within the strategy division at Accenture.
Wallace holds a BSc in Genetics from the University of York and an MPhil in Bioscience Enterprise from the University of Cambridge.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.